✦ LIBER ✦

Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer

✍ Scribed by Dobi, Erion; Monnien, Franck; Kim, Stefano; Ivanaj, Arben; N'Guyen, Thiery; Demarchi, Martin; Adotevi, Olivier; Thierry-Vuillemin, Antoine; Jary, Marie; Kantelip, Bernadette; Pivot, Xavier; Godet, Yann; Degano, Severine Valmary; Borg, Christophe

Book ID: 122426955
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 857 KB
Volume: 12
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2012.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of low-frequency KRAS mutations o

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

✍ Tougeron, D.; Lecomte, T.; Pages, J. C.; Villalva, C.; Collin, C.; Ferru, A.; To 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 159 KB

Clinical Benefit of High-Sensitivity KRA

Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy

✍ Kimura, Tetsuo; Okamoto, Koichi; Miyamoto, Hiroshi; Kimura, Masako; Kitamura, Sh 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 439 KB

Impact of pre-angiogenic factors on the

Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer

✍ Dirican, Ahmet; Kucukzeybek, Yuksel; Alacacioglu, Ahmet; Varol, Umut; Aksun, Sal 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 483 KB

522 POSTER Immunoglobulin G fragment C r

522 POSTER Immunoglobulin G fragment C receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with cetuximab-based therapy

✍ F. Negri; A. Musolino; N. Naldi; B. Bortesi; C. Boni; G. Bisagni; R. Camisa; A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

6122 POSTER Impact of Cetuximab-based Th

6122 POSTER Impact of Cetuximab-based Therapy and KRas Genotypes in Japanese Patients With Chemotherapy-refractory Metastatic Colorectal Cancer

✍ Kohnoe, S.; Saeki, H.; Emi, Y.; Ando, K.; Ohga, T.; Oki, E.; Ikeda, T.; Tsujitan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

PCN17 THE COST-EFFECTIVENESS OF CETUXIMA

PCN17 THE COST-EFFECTIVENESS OF CETUXIMAB IN COMBINATION WITH IRINOTECAN FORTHE TREATMENT OF PATIENTS WITH EGFR-EXPRESSING METASTATIC COLORECTAL CANCER AFTER FAILURE OF IRINOTECAN-INCLUDING CYTOTOXIC THERAPY IN SCOTLAND

✍ D Tilden; D Thurley; J White; M Aristides 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB